SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 143.39 |
| Enterprise Value ($M) | 94.50 |
| Book Value ($M) | 33.81 |
| Book Value / Share | 0.60 |
| Price / Book | 4.24 |
| NCAV ($M) | 30.82 |
| NCAV / Share | 0.55 |
| Price / NCAV | 4.65 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.85 |
| Return on Assets (ROA) | -0.42 |
| Return on Equity (ROE) | -0.72 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.56 |
| Current Ratio | 2.56 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 74.71 |
| Assets | 77.71 |
| Liabilities | 43.90 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 47.98 |
| Operating Income | -72.48 |
| Net Income | -68.57 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -23.44 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Glaxosmithkline Plc | 16.40 | 0.00 | |
| 13G/A | Anson Funds Management LP | 6.90 | -12.73 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| Revenue Recognition – Collaboration Revenue Tebipenem HBr Agreements SPR720 Agreements SPR206 Agreements | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 399,405 | 1,553,431 | 25.71 | |
| 874,618 | 2,463,882 | 35.50 | |
| 518,388 | 1,850,862 | 28.01 | |
| 1,822,892 | 5,998,385 | 30.39 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SDGR – Schrödinger, Inc. | SLDB – Solid Biosciences Inc. |
| SNDX – Syndax Pharmaceuticals, Inc. | SRPT – Sarepta Therapeutics, Inc. |
| SRRK – Scholar Rock Holding Corporation |
Financial data and stock pages provided by
Fintel.io